View in EDS HTML Full Text PDF Full Text

Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.

Saved in:
Bibliographic Details
Title: Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Authors: Belge Bilgin, Gokce1 (AUTHOR) Belgebilgin.gokce@mayo.edu, Burkett, Brian J.1 (AUTHOR), Bilgin, Cem1 (AUTHOR), Durski, Jolanta M.1 (AUTHOR), Packard, Ann T.1 (AUTHOR), Navin, Patrick J.1 (AUTHOR), Thorpe, Matthew P.1 (AUTHOR), Johnson, Derek R.1 (AUTHOR), Johnson, Geoffrey1,2 (AUTHOR), Halfdanarson, Thorvardur R.3 (AUTHOR), Ryder, Mabel4 (AUTHOR), Kendi, Ayse Tuba1 (AUTHOR)
Source: Journal of Nuclear Medicine. Jan2026, Vol. 67 Issue 1, p96-104. 9p.
Database: Engineering Source
Full text is not displayed to guests.
Description
ISSN:01615505
DOI:10.2967/jnumed.125.270481